Health & Life Co., Ltd. (TPEX:1781)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.00
-0.10 (-0.90%)
Apr 29, 2026, 12:49 PM CST

Health & Life Revenue

In the year 2025, Health & Life had annual revenue of 398.05M TWD, down -43.65%. Health & Life had revenue of 117.24M in the quarter ending December 31, 2025, a decrease of -27.19%.

Revenue
398.05M
Revenue Growth
-43.65%
P/S Ratio
1.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
521.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025398.05M-308.34M-43.65%
Dec 31, 2024706.39M105.22M17.50%
Dec 31, 2023601.17M-196.37M-24.62%
Dec 31, 2022797.54M-14.34M-1.77%
Dec 31, 2021811.88M37.72M4.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Taiwan Advanced Nanotech 154.37M
AmCad BioMed 30.44M
Radiant Innovation 387.58M
EPS Bio Technology 499.70M
S&S Healthcare Holding 204.21M
PlexBio 127.10M
Wiltrom 311.77M
AViTA 936.39M
Revenue Rankings